Actuated Medical Presenting at the Society for Neuroscience (SfN) ‘Neuroscience 2022’ Conference in San Diego, California

BELLEFONTE, PA – Actuated Medical will attend Neuroscience 2022, the annual meeting of SfN. Roger Bagwell, Ph.D. (Director R&D & Co-Founder) and Kyle Gheres, Ph.D. (Neural Device Leader & Senior Scientist) will be representing Actuated Medical and the NeuralGlider inserter at the NeuroNexus Booth (#: 2717). In addition, both Drs. Bagwell and Gheres will be presenting posters.

“Actuated Medical is focused on developing innovative solutions to help researchers understand the brain with our goal to help clinicians treat neurological conditions. We are proud to be presenting some of our neural device innovations like the NeuralGlider inserter that is already on the market supporting neuroscientists,” said Maureen L. Mulvihill, Actuated Medical President, CEO, and Co-Founder.

Poster Details:

Title: Delivery of Low-Intensity Pulsed Ultrasound in the Cortex to Improve Longevity and Performance of Neural Interfaces
Poster #: 460.10
Presenter: Roger Bagwell, Ph.D.
Session: # 460: Title: Traumatic Brain Injury: Developing Therapeutic Strategies
Session Time: Tuesday November 15, 8:00 AM -12:00 PM

Title: Insertion of planar and 3D matrix-style electrode arrays using ultrasonic vibration decreases electrode shank damage while maintaining electrode recording integrity
Poster #: 666.06
Presenter: Kyle Gheres, Ph.D.
Session: # 666 Title: Probing Technologies II
Session Time: Wednesday November 16, 8:00 AM -12:00 PM

Actuated Medical Awarded Phase I SBIR for Alcohol Addiction Treatment

BELLEFONTE, PA – Actuated Medical Inc. has been awarded a Phase I Small Business Innovative Research (SBIR) grant from the National Institutes of Health-National Institute on Alcohol Abuse and Alcoholism (NIH-NIAAA) entitled “Oscillated Insertion Tool for Minimally Invasive, Low-Damage, Accurate Placement of Delivery Cannula to Improve Efficacy for DREADDS Therapy in Alcohol Addiction Treatment”.

Alcohol addiction is both a major public health burden and a complex neuroscience problem. Recently, the powerful research tools used to better understand neurological disorders like addiction have also gained interest as therapies. However, a crucial issue is that the medication used must be reliably and safely delivered to specific areas within the brain. The project will demonstrate feasibility of a vibrated tool to assist in the accurate placement of a very small delivery device that may ultimately improve alcohol addiction treatment.

“Actuated is focused on developing innovative medical devices to treat neurological diseases. The goal for this technology is to use our knowledge of vibrating needles to develop a medical device that reliably enables safer and more precise injections within the brain than is currently possible, paving the way for more effective treatments for conditions like alcohol addiction,” said Maureen L. Mulvihill, Actuated Medical President, CEO, and Co-Founder.

Actuated Medical Hires a Nurse Educator to build TubeClear clinical evidence

BELLEFONTE, PA – Actuated Medical is pleased to welcome Paula M. Mulhall, RPN, RGN, RN, to the Actuated Medical team as their Nurse Educator. Using her clinical nursing background in medicine/surgery, head trauma, spinal cord injury rehab, and long-term care, she will focus on the development of TubeClear clinical evidence through communications and collaboration with various medical facilities and personnel. The TubeClear system is an FDA cleared medical device that clears feeding tubes while the tube stays in the patient and operates at bedside.

“Paula’s experience dealing with clogged feeding tubes during her career gives her the passion and understanding of the nursing issue that TubeClear solves. She is an excellent addition to the TubeClear team,” said Maureen L. Mulvihill, Actuated Medical President, CEO, and co-Founder.

About Paula M. Mulhall, RPN, RGN, RN Paula is a Registered Psychiatric Nurse and General Nurse with a diploma in Behavioral Science from the Royal College of Surgeons in Dublin, Ireland. She boasts a clinical nursing background in Medicine/Surgery, Acute Psychiatry, Head Trauma, Spinal Cord Injury Rehab, and Long Term Care. In 1995, she began her research nursing career at the Pennsylvania State University (PSU), as a Clinical Research Nurse at the General Clinical Research Center (GCRC), where she assisted with all medical aspects of invasive clinical studies and trials with participants ranging in age from 3 to 90 year-olds. During this time, she coordinated the inaugural 5 year Nationwide Diabetes Prevention Trial (DPT-1) and assumed the role of Nurse Manager of the GCRC for 4 years before transitioning to PSU’s College of Nursing in 2010 as the Project Director of an National Institutes of Health 5- year Clinical Trial on Delirium Superimposed on Dementia. She completed her PSU career working in Social Science research for 6 years in the field of Child Maltreatment. During her time at PSU, she also volunteered as an alternative member of the Internal Review Board for 7 years.

Actuated Medical New Headquarters enables Greater Team Collaboration

BELLEFONTE, PA – Actuated Medical has officially moved its Headquarters to 320 Rolling Ridge Drive, Bellefonte, PA 16823. The move enables Actuated to expand their state-of-the-art facility from 9,000 to 20,000 sq ft. which includes a neurotechnology development lab, rapid prototyping and manufacturing lab, FDA compliant controlled manufacturing area, and our expanded machine shop. The larger, collaborative environment allows the Actuated Team to develop innovative neuro devices that will help clinicians treat neurological conditions. 

“By moving the Actuated Team into one building and expanding our capabilities, we have a greater capacity to develop innovative medical devices that improve patient outcomes more efficiently.  With the added benefit that central Pennsylvania is a great place to grow a company,” said Maureen L. Mulvihill, Actuated Medical President, CEO, and Co-Founder.

K. Marya Chaisson, M.D. Appointed to Actuated Medical’s Medical Advisory Board

Actuated Medical appointed K. Marya Chaisson, M.D. to the Medical Advisory Board. Dr. Chaisson advises the Actuated team on critical care, sleep medicine, and pulmonary standard practice. She is the Medical Director of critical care, medical student affairs, and the Sleep Wellness Center at Griffin Hospital in Derby, CT. Dr. Chaisson has also been Co-Chair of the Patient-Centered Care Council at Griffin Hospital since 2008.

“Dr. Chaisson brings a patient-focused approach to Actuated Medical ensuring the patient is the focus of all our medical device design. Her expertise will help move Actuated move up and onward,” said Maureen Mulvihill, President and CEO of Actuated Medical.

“I have been thoroughly impressed with the growth and innovation of Actuated Medical over the years. I am excited to be a member of their Medical Advisory Board and provide my perspective on projects that will help patients along their health journey,” said Marya Chaisson, M.D., Medical Advisory Board Member at Actuated Medical.

Dr. Chaisson’s values strongly align with Actuated’s mission to improve patient outcomes. She is known for being empathetic to her patient’s diagnoses on a personal level, thereby furthering her level of care. Dr. Chaisson brings Actuated’s Medical Advisory Board to a strong seven members total. The board advises on civilian and military medical needs, clinical best practices, clinical and device usability, health economics, and hospital purchasing.